Global Liver Institute

Is Your Liver Healthy?

GLOBAL LIVER INSTITUTE

Is Your Liver Healthy?

At Global Liver Institute, we believe it all starts with a patient.

Did you know that an estimated 1.5 billion people around the world are affected by a liver condition?

This fact might lead you to the core question of this show: Is Your Liver Healthy? In monthly conversations, our host Jeff McIntyre explores a new part of the answer to this question by sitting down with the people who know the most about liver health and related conditions – whether that’s through their medical research, training and practice, personal experiences, or professional work. Join each month to learn what affects liver health, how liver disease impacts lives, and the actions we can all take to improve liver health for ourselves and our communities.

“Is Your Liver Healthy?” is produced by Global Liver Institute (GLI). It was born out of the interview show GLI LIVE, which GLI started in March 2020 as a COVID-19 response program for liver patients.

Check out the show on YouTube, Spotify, Apple Podcasts, Amazon Music, Audible, or wherever you get your podcasts!

Is Your Liver Healthy Podcast Logo
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, obesity, kidney disease, and other conditions. These drugs mimic GLP-1, a hormone that affects insulin release, slows stomach emptying, and affects satiety. Early studies suggest that GLP-1 drugs can benefit liver health as well. Explore the basics and what liver patients should know about GLP-1s with this month's guests:

Joe Naglowski, President & CEO, Obesity Action Coalition (https://www.obesityaction.org/)
Dr. Janese Laster, Gastroenterologist & founder of Gut Theory Total Digestive Care (https://www.guttheoryhealth.com/)

This video is private.

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy41MjE1MkI0OTQ2QzJGNzNG

GLP-1s & Your Liver (Is Your Liver Healthy? Episode 3)